hrp 112 has been researched along with ethinyl estradiol in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cromie, MA; Garceau, RJ; Kaunitz, AM | 1 |
| Oleen-Burkey, M; Shulman, LP; Willke, RJ | 1 |
| Cromie, MA; Maile, MH; Wajszczuk, CP | 1 |
| Jain, JK; Mishell, DR; Ota, F | 1 |
| Garceau, RJ; Kaunitz, AM; Wajszczuk, CJ | 1 |
6 trial(s) available for hrp 112 and ethinyl estradiol
| Article | Year |
|---|---|
Comparative safety, efficacy, and cycle control of Lunelle monthly contraceptive injection (medroxyprogesterone acetate and estradiol cypionate injectable suspension) and Ortho-Novum 7/7/7 oral contraceptive (norethindrone/ethinyl estradiol triphasic). Lu
Topics: Contraceptive Agents, Female; Contraceptives, Oral, Combined; Drug Combinations; Estradiol; Ethinyl Estradiol; Female; Humans; Injections, Intramuscular; Medroxyprogesterone Acetate; Menstrual Cycle; Metrorrhagia; Norethindrone; Patient Compliance; Pregnancy; Weight Gain | 1999 |
Patient acceptability and satisfaction with Lunelle monthly contraceptive injection (medroxyprogesterone acetate and estradiol cypionate injectable suspension).
Topics: Adolescent; Adult; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Contraceptives, Oral, Sequential; Contraceptives, Oral, Synthetic; Drug Combinations; Estradiol; Ethinyl Estradiol; Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Patient Satisfaction; Surveys and Questionnaires | 1999 |
Comparative effects of Lunelle monthly contraceptive injection (medroxyprogesterone acetate and estradiol cypionate injectable suspension) and ortho-Novum 7/7/7 oral contraceptive (norethindrone/ethinyl estradiol triphasic) on lipid profiles. Investigator
Topics: Apolipoprotein A-I; Apolipoprotein A-II; Apolipoproteins B; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Drug Combinations; Estradiol; Female; Humans; Lipids; Medroxyprogesterone Acetate; Mestranol; Norethindrone; Triglycerides | 2000 |
Comparison of ovarian follicular activity during treatment with a monthly injectable contraceptive and a low-dose oral contraceptive.
Topics: Adult; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Drug Combinations; Estradiol; Ethinyl Estradiol; Female; Humans; Injections; Levonorgestrel; Medroxyprogesterone Acetate; Ovarian Follicle; Prospective Studies; Ultrasonography | 2000 |
Bleeding patterns of women using Lunelle monthly contraceptive injections (medroxyprogesterone acetate and estradiol cypionate injectable suspension) compared with those of women using Ortho-Novum 7/7/7 (norethindrone/ethinyl estradiol triphasic) or other
Topics: Adolescent; Adult; Amenorrhea; Body Weight; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Drug Combinations; Estradiol; Female; Humans; Medroxyprogesterone Acetate; Mestranol; Middle Aged; Norethindrone; Patient Compliance; Uterine Hemorrhage | 2000 |
Comparative study of the effects of two once-a-month injectable contraceptives (Cyclofem and Mesigyna) and one oral contraceptive (Ortho-Novum 1/35) on coagulation and fibrinolysis.
Topics: Adolescent; Adult; Antithrombins; Blood Coagulation; Cardiovascular Diseases; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Drug Combinations; Estradiol; Factor VII; Factor X; Female; Fibrinogen; Fibrinolysis; Hemoglobins; Humans; Injections; Medroxyprogesterone Acetate; Mestranol; Norethindrone; Partial Thromboplastin Time; Plasminogen; Plasminogen Inactivators; Platelet Count; Protein C; Prothrombin | 2003 |